Ludwig Jeffrey Jerome 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Jul 2, 2024
Insider Transaction Report
Form 4
Ludwig Jeffrey Jerome
Chief Commercial Officer
Transactions
- Sale
Common Stock
2024-07-02$3.27/sh−6,051$19,778→ 120,986 total
Footnotes (2)
- [F1]Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2601 to $3.3101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.